Araceli Biosciences develops technologies that empower researchers to accelerate therapeutic discovery, pursuing advancements in predictive AI-based image acquisition and analysis.

Araceli Biosciences

Araceli Biosciences | 2,766 followers on LinkedIn. Do more. See more. Discover more. | Blending technology and science, we develop instrumentation to improve outcomes.

Araceli Biosciences delivers high-performance scientific tools for tissue and cell-based biomarker discovery, drug discovery and drug development. With decades of combined biomedical research and instrument design experience, we are focused on developing scientific instrumentation to improve outcomes and enable our customers to advance scientific and medical research.

Founder and CEO at BioAdvisors, LLC

Kirk Malloy

VP WW Sales and Support at Araceli Biosciences

Jonathan Day

Product Development Leader

Ron Peters

Chief Operating Officer

Sam Raha

Happy Halloween from the Araceli team! 🎃

Exciting day in Boston! Join us tonight at 7:30 PM for the LRIG-NE x Boston Lab Automators afterparty at Locke Bar in Cambridge. Stop by to network and geek out on all things #laboratoryautomation ! Drop a comment or message us to get your ticket!

Throwback to last year's Merck Technology Symposium in NJ! Tomorrow we'll be back at Merck Imaging Day in Cambridge, MA. Come chat with our team and see the latest advances in ultra-fast imaging technology! #mercktechnologysymposium #merckimagingday #highcontentimaging #highcontentscreening

We are so excited to see you at the LRIG NE Fall Seminar tomorrow! In the 5 hours of the event, how many 1536 well plates do you think you could image with Araceli Endeavor® in your lab? Drop your guess in the comments below, we'll post the right answer and send a T-shirt to the winner! #bostonbiotech #LRIGNewEngland #LRIG #laboratoryautomation #highcontentimaging

Our team is thrilled to be at the LRIG Bay Area event today! Come say hi, learn the power of ultra-fast High Content Imaging! #LRIGBayArea #Networking #Innovation

ELRIG Day 1 was a blast!! Meet us at stand A12 to see the fastest high content imaging platform on the planet. Today Dr. Martin Theiss (PhD) will be talking about transforming high content imaging into high throughput! Join us in Auditorium 1 at 12:35 pm to see the latest applications of ultra-fast phenotypic screening for #drugdiscovery . #elrigdd2024 #elriguk #drugdiscovery2024

SBI2 is off to a great start! Stop by booth #7 to see the fastest HCI platform on the planet in action! Our team can’t wait to see you. What was your favorite part so far of #SBI22024 ?

You don't want to miss this!! If you are at Society of Biomolecular Imaging and Informatics , come to our Lunch and Learn Session in St. George (D Room), where Claudia McCown, PhD from the Spicer Lab at Scripps Research Institute will be talking about the results of combining ultra-fast HCA imaging and binary AI to identify modulators in neurite outgrowth. See you at 1 pm! Attendees will be entered for a chance to win an Apple Watch Series 10.

With Endeavor in the lab, what would you do with all the time in your hands?? Claudia McCown, PhD from the Spicer Lab at the UF Scripps Institute will be speaking on combining HCA imaging with binary AI to identify modulators of neurite outgrowth at the Society of Biomolecular Imaging and Informatics event this Thursday at 1 pm!! Attendees will be entered for a chance to win an Apple Watch! We can't wait to see you there.

AI has a data problem: there's too little quality biological data to keep up with validation and training of advanced drug discovery models. In his talk today, Matt Beaudet shared critical insights to answer one of the most crucial questions in drug discovery today, pointing to the power of ultra-fast cell imaging and analysis to bridge the gap between digital models and real-world therapeutics. Catch Matt and our team at DDIF today and tomorrow—we’d love to connect and share our vision for the future of drug discovery! #DDIF #DDIF2024 #drugdiscovery #techbio #aidrugdiscovery #ai

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 12, 2024 10:02 AM	d85f7cdf
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 12, 2024 10:02 AM	ec59a819
crunchbase trigger	general	Nov 27, 2024 12:50 PM	8a6332df
crunchbase profile	general
li profile	general	Nov 12, 2024 10:02 AM	d0deeca4
translate crunchbase fundingrounds	general
peers	general	Nov 12, 2024 10:02 AM	f83f64b0
news basic	general	Nov 12, 2024 10:02 AM	bde41e4c
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

ARAC

COM:ARACELIBIO

Araceli Biosciences